EUVIMEDEUVIMED entdecken
Crossref

Early response and long‐term prognosis of paediatric ITP: Exploration of future management strategies

Minghao Zhang, Xiaoming Wang iD, Ting Pu, Xiaoyu Jiao, Ting Li iD, Jie Wei, Yuxuan Cheng, Wan Zhang, Jun Peng, Aijun Zhang iD

British Journal of Haematology · 2025

DOI: 10.1111/bjh.20209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Minghao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong Province, China. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Immunoglobulins, Intravenous. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: The National Key R&D Program of China, Qilu Medical Development Fund of Shandong University, Shandong University Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune thrombocytopenia (ITP) is the most common immunological haemorrhagic disease in childhood. Our retrospective study analysed hospitalized paediatric ITP patients to identify determinants of early treatment response and long‐term clinical outcomes. The study found that younger children had a higher 7‐day complete response (CR) rate and were more likely to achieve CR in the early stages ( p = 0.003, hazard ratio = 0.960 [0.934–0.986]). There was no difference in early partial response or CR rates between subgroups of intravenous immunoglobulin at different doses ( p > 0.05). Age was identified as an independent factor affecting long‐term prognosis, with older children experiencing a longer duration of illness ( p < 0.001, odds ratio = 1.225 [1.143–1.309]). The long‐term prognosis was not influenced by early treatment response. Despite this, current first‐line treatments for children cannot prevent disease recurrence or improve long‐term outcomes. Whether treatment strategies based on risk stratification and early combination of second‐line treatments can decrease glucocorticoid use, reduce the likelihood of chronic ITP, improve quality of life and optimize long‐term prognosis remains to be determined. The optimization of treatment regimens based on risk stratification warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicImmunoglobulins, IntravenousHumansChildMaleFemaleChild, PreschoolPrognosisRetrospective StudiesAdolescentInfantTreatment OutcomeAge FactorsDisease Management

Stichwörter der Autor:innen

early responselong‐term prognosispaediatric immune thrombocytopenia

Substanzen

Immunoglobulins, Intravenous

Autor:innen und Institutionen

  • Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong Province, China.
  • Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong Province, China.

ORCID-Profile: Xiaoming Wang, Ting Li, Aijun Zhang

Förderung

  • The National Key R&D Program of China
  • Qilu Medical Development Fund of Shandong University
  • Shandong University Joint Fund

Zitieren

APA

Zhang, M., Wang, X., Pu, T., Jiao, X., Li, T., Wei, J., Cheng, Y., Zhang, W., Peng, J., & Zhang, A. (2025). Early response and long‐term prognosis of paediatric ITP: Exploration of future management strategies. British Journal of Haematology. https://doi.org/10.1111/bjh.20209

Vancouver

Zhang M, Wang X, Pu T, Jiao X, Li T, Wei J, et al. Early response and long‐term prognosis of paediatric ITP: Exploration of future management strategies. British Journal of Haematology. 2025. doi:10.1111/bjh.20209

BibTeX
@article{Zhang2025,
  author = {Zhang, Minghao and Wang, Xiaoming and Pu, Ting and Jiao, Xiaoyu and Li, Ting and Wei, Jie and Cheng, Yuxuan and Zhang, Wan and Peng, Jun and Zhang, Aijun},
  title = {Early response and long‐term prognosis of paediatric ITP: Exploration of future management strategies},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.20209}
}
Kostenlos starten →